S&P 500
7,757.17
+44.60
+0.58%
Dow
52,856.09
+360.21
+0.69%
Nasdaq
26,702.86
+278.04
+1.05%
NYSE Composite
24,253.12
+62.51
+0.26%
Russell 2000
2,781.02
+7.60
+0.27%
VIX
16.68
-0.63
-3.64%
OFIX · Orthofix Medical Inc. Common Stock (DE)
NASDAQ NMS - GLOBAL MARKET - BOATS Real Time Price • USD
Orthofix Medical Inc (OFIX)
NASDAQ NMS - GLOBAL MARKET
Health Care
$9.76
-0.10
(-1.01%)
● At close: October 21 at 4:00:00 PM EDT
DAY'S RANGE
$9.76
$9.74
$9.92
52-WEEK RANGE
$9.76
$8.50
$16.99
What's happening
- OFIX is down 1.01% today, trading at $9.76. — Live quote
- Volume today (31,685) is well below its 3-month average of 381,950. (Finnhub fundamentals)
- Reports earnings on 2026-11-11, 20 days away. (Finnhub earnings calendar)
- Last quarter's EPS beat estimates: $-0.39 actual vs. $-0.42 estimated (+6.7%). (Finnhub earnings history)
Deterministic template sentences filled in from the same sourced figures shown elsewhere on this page -- not an AI-written summary, no live model call.
Key Statistics
Analyst Recommendations
Strong buy 4
Buy 4
Hold 3
Sell 0
Strong sell 0
Aggregate ratings for 2026-10-01 (11 analysts polled by Finnhub) — consensus count.
Performance Overview (Trailing returns vs S&P 500 benchmark)
YTD RETURN
OFIX
-35.03%
vs S&P 500
-47.80%
1-YEAR RETURN
OFIX
-36.94%
vs S&P 500
-51.50%
6-MONTH RETURN
OFIX
-20.50%
3-MONTH RETURN
OFIX
-15.31%
Earnings Trends (Quarterly EPS Actual vs Estimate)
2026-07-26 (Q2 2026)
$-0.39
Est. $-0.42
BEAT +6.7%
2026-04-26 (Q1 2026)
$-0.13
Est. $-0.69
BEAT +81.3%
2026-01-26 (Q4 2025)
$-0.06
Est. $-0.32
BEAT +81.0%
2025-10-26 (Q3 2025)
$-0.57
Est. $-0.41
MISS -37.4%
Valuation Measures & Ratios
Enterprise Value4$527.5M
Forward P/E5—
PEG Ratio6—
Price / Sales (TTM1)0.48
Price / Book70.86
EV4 / Revenue0.63
EV4 / EBITDA277.66
Profit Margin-7.41%
Operating Margin-4.70%
Return on Equity (ROE8)-14.05%
Return on Assets (ROA9)-7.17%
Avg Volume (3M)381,950
Quarterly history (5 periods)
| Measure | Jun '26 | Mar '26 | Sep '25 | Jun '25 | Mar '25 |
|---|---|---|---|---|---|
| Market cap | $370.6M | $459.8M | $585.9M | $436.5M | $642.2M |
| P/E | -5.04 | -4.15 | -4.99 | -3.41 | -4.28 |
| Price/Sales | 0.45 | 0.58 | 0.73 | 0.55 | 0.83 |
| Price/Book | 0.86 | 1.06 | 1.32 | 0.95 | 1.40 |
| EV/Revenue | 0.60 | 0.70 | 0.85 | 0.67 | 0.95 |
| EV/EBITDA | 509.31 | -30.12 | -31.78 | — | — |
| ROE | -17.14% | -25.48% | -26.52% | -27.93% | -32.72% |
| ROA | -8.43% | -12.51% | -14.10% | -15.29% | -18.22% |
Trailing-twelve-month ratios computed from SEC EDGAR quarterly figures and historical daily close prices (Alpaca). Diluted shares are derived from Net income ÷ EPS (diluted) for each quarter, not separately reported. Forward P/E/PEG unavailable (no free data source).
Glossary — what these abbreviations mean
- 1. TTM
- Trailing twelve months — the sum of the last four reported quarters, not a calendar year or the single latest quarter.
- 2. EPS
- Earnings per share — net income divided by diluted shares outstanding.
- 3. Beta
- A stock's historical volatility relative to the overall market. Above 1 means it has moved more than the market; below 1, less.
- 4. EV (Enterprise Value)
- Market cap plus total debt minus cash — roughly what it would cost to buy the whole company, debt included.
- 5. Forward P/E
- Price divided by analysts' estimated earnings for the next 12 months, instead of trailing actual earnings.
- 6. PEG Ratio
- P/E divided by expected earnings growth rate. A lower number can indicate a stock is cheap relative to how fast it's expected to grow.
- 7. Price / Book
- Share price divided by book value (assets minus liabilities) per share.
- 8. ROE
- Return on equity — net income divided by shareholders' equity, a measure of how efficiently a company turns equity into profit.
- 9. ROA
- Return on assets — net income divided by total assets, a measure of how efficiently a company turns assets into profit.
- 10. MRQ
- Most recent quarter — the single latest reported period, as opposed to TTM. The Financials section's "Quarterly" view below shows MRQ-style figures.
- 11. YoY
- Year over year — percent change versus the same period one year earlier, used for growth figures like those on Compare cards and the Screener.
Short Interest
Shares Short2,442,442
Change from Prior Settlement-2.56%
% of Float—
Days to Cover (Short Ratio)5.49
Source: FINRA Rule 4560 consolidated short interest, settlement date 2026-09-30. Reported bi-monthly with a reporting lag — not real-time.
Quotes and the 1-day extended-hours chart: Yahoo Finance. Longer historical charts: Alpaca (IEX feed) — real-time but IEX-only volume (~2.5% of consolidated market volume). Fundamentals + earnings: Finnhub.
Price history
Events
Drag horizontally to zoom into a section; use Reset view to restore all observations.
Technical signal summary
Calculating from the latest year of daily price history…
Show Technical Analysis Breakdown ▾ 10 Indicators
Not investment advice — read several signals together.
Indicators None active
Loading chart…
History limited by data provider; markers are heuristics, not signals.
Peer and sector context
No reviewed peer group is available for this symbol.
Balanced evidence
A deterministic summary of sourced facts—not an AI verdict.
Potential strengths
- Revenue growth is 3.9% on the provider's reported measure. Finnhub fundamentals ↗
- Latest SEC filing is Form 4, filed 2026-10-05; review it for current changes and risks. SEC EDGAR ↗
Potential concerns
- Net profit margin is -7.4%. Finnhub fundamentals ↗
- Trailing 52-week price return is -36.9%. Finnhub market metrics ↗
Rule-based facts only; absence from either side is not evidence, and this is not a recommendation.
More on OFIX
No accessible free API for these — links go to the source directly.
Financials
Fundamental trends
Visualized from the same SEC figures in the tables below.
Income statement
| Line item | Jun '26 | Mar '26 | Sep '25 | Jun '25 | Mar '25 | Sep '24 | Jun '24 | Mar '24 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $210.9M | $196.7M | $205.6M | $203.1M | $193.6M | $196.6M | $198.6M | $188.6M |
| Gross profit | $149.7M | $139.5M | $148.5M | $139.5M | $121.6M | $135.1M | $134.7M | $127.2M |
| Operating income | -$8.1M | -$14.4M | -$17.0M | -$16.0M | -$48.9M | -$18.9M | -$24.9M | -$29.3M |
| Net income | -$15.8M | -$20.9M | -$22.8M | -$14.1M | -$53.1M | -$27.4M | -$33.4M | -$36.0M |
| EPS (diluted) | $-0.39 | $-0.52 | $-0.57 | $-0.36 | $-1.35 | $-0.71 | $-0.88 | $-0.95 |
| EPS (basic) | $-0.39 | $-0.52 | $-0.57 | $-0.36 | $-1.35 | $-0.71 | $-0.88 | $-0.95 |
| Operating margin | -$4 | -$7 | -$8 | -$8 | -$25 | -$10 | -$13 | -$16 |
| Net margin | -$7 | -$11 | -$11 | -$7 | -$27 | -$14 | -$17 | -$19 |
Balance sheet
| Line item | Jun '26 | Mar '26 | Dec '25 | Sep '25 | Jun '25 | Mar '25 | Dec '24 | Sep '24 |
|---|---|---|---|---|---|---|---|---|
| Total assets | $873.0M | $886.6M | $850.6M | $832.6M | $837.2M | $823.1M | $893.3M | $867.9M |
| Total liabilities | $443.8M | $451.4M | $400.6M | $390.1M | $378.8M | $364.9M | $390.2M | $341.9M |
| Stockholders' equity | $429.2M | $435.2M | $450.0M | $442.5M | $458.3M | $458.3M | $503.1M | $525.9M |
| Total current assets | $446.1M | $461.5M | $416.8M | $394.2M | $395.8M | $390.3M | $433.3M | $386.2M |
| Total current liabilities | $157.0M | $161.0M | $170.5M | $159.8M | $148.4M | $144.1M | $168.6M | $161.9M |
| Cash & equivalents | $103.8M | $120.3M | $82.0M | $62.9M | $65.6M | $58.0M | $83.2M | $30.1M |
| Accounts receivable | $135.8M | $137.8M | $135.7M | $130.8M | $129.6M | $131.9M | $134.7M | $124.8M |
| Inventory | $184.5M | $177.8M | $172.3M | $174.0M | $173.0M | $174.5M | $189.5M | $205.8M |
| Property, plant & equipment | $130.8M | $125.3M | $129.4M | $130.0M | $129.2M | $130.7M | $139.8M | $146.7M |
| Goodwill | $194.9M | $194.9M | $194.9M | $194.9M | $194.9M | $194.9M | $194.9M | $194.9M |
| Intangible assets | $66.0M | $69.3M | $72.8M | $75.6M | $78.9M | $81.2M | $98.8M | $104.5M |
| Other non-current assets | $35.2M | $35.5M | $36.7M | $37.8M | $38.3M | $26.0M | $26.5M | $35.5M |
| Accounts payable | $63.5M | $54.7M | $58.4M | $50.5M | $45.1M | $45.2M | $48.8M | $47.1M |
| Accrued liabilities | — | $23.3M | — | — | — | — | — | — |
| Short-term debt | — | — | $0 | — | — | — | $0 | $6.2M |
| Other current liabilities | $93.4M | $106.2M | $111.3M | $108.6M | $102.5M | $98.2M | $119.1M | $107.8M |
| Long-term debt | $221.6M | $221.3M | $157.4M | $157.2M | $157.0M | $156.9M | $157.0M | $112.2M |
| Other non-current liabilities | $52.3M | $56.1M | $55.7M | $55.8M | $55.9M | $46.2M | $46.7M | $49.8M |
| Common stock & paid-in capital | $4.1M | $4.0M | $4.0M | $4.0M | $3.9M | $3.9M | $3.8M | $3.8M |
| Retained earnings | -$405.0M | -$389.2M | -$368.3M | -$366.1M | -$343.3M | -$329.2M | -$276.1M | -$247.0M |
| Accumulated other comprehensive income (loss) | -$277.0K | $142.0K | $618.0K | $634.0K | $908.0K | -$2.6M | -$4.3M | -$902.0K |
Cash flow
| Line item | Jun '26 | Mar '26 | Dec '25 | Sep '25 | Jun '25 | Mar '25 | Dec '24 | Sep '24 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | -$6.2M | -$17.6M | $27.7M | $12.4M | $11.6M | -$18.4M | $23.7M | $11.7M |
| Investing cash flow | -$12.6M | -$10.5M | -$10.9M | -$9.9M | -$7.1M | -$6.7M | -$1.1M | -$5.9M |
| Financing cash flow | $2.5M | $64.0M | $2.4M | -$5.2M | $2.6M | -$651.0K | $31.5M | -$2.5M |
| Free cash flow | — | — | — | — | — | — | — | $6.3M |
| Capital expenditures | — | — | — | — | — | — | — | $5.3M |
| Depreciation & amortization | $13.3M | $13.5M | $42.9M | $12.9M | $16.9M | $34.4M | $45.2M | $15.2M |
| Share-based compensation | $7.7M | $6.5M | $7.2M | $7.2M | $7.8M | $6.5M | $7.2M | $6.5M |
| Deferred income taxes | $339.0K | $93.0K | -$110.0K | $321.0K | -$433.0K | $445.0K | $378.0K | $325.0K |
| Change in accounts receivable | $1.1M | $3.0M | $4.7M | $2.0M | -$2.7M | -$2.4M | $10.8M | -$591.0K |
| Change in inventory | $12.1M | $8.8M | $1.3M | $3.6M | $6.6M | -$693.0K | -$4.3M | $1.2M |
| Change in accounts payable | $4.9M | -$4.4M | $8.3M | $3.5M | -$6.6M | -$2.5M | $5.8M | -$3.9M |
| Purchases of investments | — | — | — | — | — | — | — | — |
| Sales/maturities of investments | — | — | — | — | — | — | $7.4M | — |
| Other investing activities | $0 | -$146.0K | -$6.0K | -$10.0K | -$12.0K | — | $0 | $50.0K |
| Share repurchases | — | — | — | — | — | — | — | — |
| Tax withholding on stock comp | $150.0K | — | $264.0K | $9.0K | $159.0K | — | $365.0K | $1.2M |
| Other financing activities | — | — | — | — | — | — | — | — |
Income statement
| Line item | Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 |
|---|---|---|---|---|---|
| Revenue | $822.3M | $799.5M | $746.6M | $460.7M | $464.5M |
| Gross profit | $566.0M | $545.9M | $486.3M | $337.2M | $349.6M |
| Operating income | -$81.4M | -$84.6M | -$139.1M | -$13.3M | -$8.3M |
| Net income | -$92.2M | -$126.0M | -$151.4M | -$19.7M | -$38.4M |
| EPS (diluted) | $-2.33 | $-3.30 | $-4.12 | $-0.98 | $-1.95 |
| EPS (basic) | $-2.33 | $-3.30 | $-4.12 | $-0.98 | $-1.95 |
| Operating margin | -$10 | -$11 | -$19 | -$3 | -$2 |
| Net margin | -$11 | -$16 | -$20 | -$4 | -$8 |
Balance sheet
| Line item | Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 |
|---|---|---|---|---|---|
| Total assets | $850.6M | $893.3M | $925.3M | $458.6M | $476.6M |
| Total liabilities | $400.6M | $390.2M | $326.6M | $121.8M | $139.7M |
| Stockholders' equity | $450.0M | $503.1M | $598.7M | $336.9M | $336.9M |
| Total current assets | $416.8M | $433.3M | $420.4M | $256.0M | $269.5M |
| Total current liabilities | $170.5M | $168.6M | $165.2M | $83.6M | $105.8M |
| Cash & equivalents | $82.0M | $83.2M | $33.1M | $50.7M | $87.8M |
| Accounts receivable | $135.7M | $134.7M | $128.1M | $82.9M | $78.6M |
| Inventory | $172.3M | $189.5M | $222.2M | $100.2M | $83.0M |
| Property, plant & equipment | $129.4M | $139.8M | $159.1M | $58.2M | $59.3M |
| Goodwill | $194.9M | $194.9M | $194.9M | $71.3M | $71.3M |
| Intangible assets | $72.8M | $98.8M | $117.5M | $47.4M | $52.7M |
| Other non-current assets | $36.7M | $26.5M | $33.4M | $25.7M | $23.9M |
| Accounts payable | $58.4M | $48.8M | $58.4M | $27.6M | $26.5M |
| Accrued liabilities | — | — | $7.0M | — | — |
| Short-term debt | $0 | $0 | $1.2M | — | — |
| Other current liabilities | $111.3M | $119.1M | $104.9M | $55.4M | $76.8M |
| Long-term debt | $157.4M | $157.0M | $93.1M | — | — |
| Other non-current liabilities | $55.7M | $46.7M | $49.7M | $18.9M | $14.0M |
| Common stock & paid-in capital | $4.0M | $3.8M | $3.7M | $2.0M | $2.0M |
| Retained earnings | -$368.3M | -$276.1M | -$150.1M | $1.3M | $21.0M |
| Accumulated other comprehensive income (loss) | $618.0K | -$4.3M | -$1.3M | -$1.4M | — |
Cash flow
| Line item | Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 |
|---|---|---|---|---|---|
| Operating cash flow | $33.3M | $25.8M | -$45.8M | -$11.5M | $18.5M |
| Investing cash flow | -$34.6M | -$27.6M | -$33.1M | -$24.5M | -$23.0M |
| Financing cash flow | -$786.0K | $50.7M | $65.3M | -$78.0K | -$3.6M |
| Free cash flow | — | — | -$106.0M | -$32.9M | $690.0K |
| Capital expenditures | — | — | $60.3M | $21.4M | $17.8M |
| Depreciation & amortization | $77.3M | $60.1M | $53.1M | $29.0M | $29.6M |
| Share-based compensation | $28.7M | $32.5M | $35.7M | $18.4M | $15.4M |
| Deferred income taxes | $223.0K | $1.9M | $579.0K | $314.0K | $24.5M |
| Change in accounts receivable | $1.6M | $9.5M | $10.4M | $6.7M | $7.0M |
| Change in inventory | $10.7M | $5.5M | $58.1M | $33.0M | $10.2M |
| Change in accounts payable | $2.6M | -$5.6M | $8.6M | $2.3M | $4.3M |
| Purchases of investments | — | — | — | — | $2.2M |
| Sales/maturities of investments | — | $7.4M | — | $126.0K | — |
| Other investing activities | -$28.0K | $100.0K | $500.0K | -$126.0K | $1.2M |
| Share repurchases | — | — | — | — | — |
| Tax withholding on stock comp | $432.0K | $5.3M | $4.4M | $1.7M | $2.6M |
Source: SEC EDGAR XBRL filings (10-Q/10-K), as originally tagged by the company. Quarterly cash flow is reconstructed by de-cumulating fiscal-year-to-date figures (how cash flow is tagged in 10-Qs); other quarterly lines are reported directly.
Institutional holders
SEC Form 13F filers holding OFIX as of the latest reported quarter. 13F only covers investment managers with $100M+ in assets — this is not a complete ownership picture, and does not include insiders (see Recent SEC filings below) or non-13F-eligible holders.
Institutional ownership is not available for this symbol right now.
Insider activity
Directors, officers, and 10%+ owners' reported transactions from SEC Form 4. A filing reports a transaction; it does not by itself explain why it happened.
Source: SEC EDGAR Form 4 filings · checked 25 most recent filings · covers 2026-03-04 to 2026-10-01
Recent transactions
- Insiders have net sold 406,869 shares over the last 182 days, across 9 purchases and 9 sales.
- Most recent: Fisher Patrick (President, Global Limb Recon) — Open market sale of 150 shares on 2026-10-01.
Deterministic template sentences filled in from the SEC Form 4 figures in the tables below -- not an AI-written summary, no live model call.
Insider purchases & sales, last 6 months
Purchases (open market)189,896 sh(9 txns)
Sales (open market)596,765 sh(9 txns)
Net Shares-406,869
Counts only open-market purchases (code P) and sales (code S) — grants, option exercises, tax withholding, and gifts are excluded since they aren't a market buy/sell decision.
Insider roster
| Name | Title | Most Recent Transaction | Date | Shares |
|---|---|---|---|---|
| Fisher Patrick | President, Global Limb Recon | Open market sale | 2026-10-01 | 150 |
| Juniper Investment Company, LLC | 10% owner | Open market sale | 2026-09-21 | 190,000 |
| McPherron Aviva | Pres, Global Ops & Qual | Open market sale | 2026-06-18 | 3,670 |
| Bazaar Alan Lee | Reporting person | Grant / award | 2026-06-10 | 14,965 |
| Kummeth Charles R. | Reporting person | Grant / award | 2026-06-10 | 14,965 |
| Hannon Jason | Reporting person | Grant / award | 2026-06-10 | 14,965 |
| Finegan Michael | Reporting person | Grant / award | 2026-06-10 | 20,721 |
| CAPPS VICKIE L | Reporting person | Grant / award | 2026-06-10 | 14,965 |
| HENNEMAN JOHN B III | Reporting person | Grant / award | 2026-06-10 | 14,965 |
| BURRIS WAYNE | Reporting person | Grant / award | 2026-06-10 | 14,965 |
| Maniar Shweta | Reporting person | Grant / award | 2026-06-10 | 14,965 |
| Paolucci Michael E | Reporting person | Grant / award | 2026-06-10 | 14,965 |
| Engine Capital Management, LP | 10% owner | Open market purchase | 2026-05-07 | 18,192 |
| Cedron Jorge Andres | CLO | Open market sale | 2026-04-16 | 3,743 |
| Vitale Lucas | CP&BOO | Open market sale | 2026-03-17 | 4,269 |
| Andrews Julie | CFO | Open market sale | 2026-03-05 | 2,363 |
| Calafiore Massimo | President & CEO | Open market sale | 2026-03-05 | 6,031 |
Recent transactions
| Date | Insider | Title | Transaction | Shares | Price |
|---|---|---|---|---|---|
| 2026-10-01 | Fisher Patrick | President, Global Limb Recon | Open market sale | 150 | $9.44 |
| 2026-09-21 | Juniper Investment Company, LLC | 10% owner | Open market sale | 190,000 | $8.86 |
| 2026-09-18 | Juniper Investment Company, LLC | 10% owner | Open market sale | 120,000 | $8.74 |
| 2026-09-01 | Fisher Patrick | President, Global Limb Recon | Open market sale | 150 | $9.39 |
| 2026-08-18 | Fisher Patrick | President, Global Limb Recon | Open market sale | 1,295 | $10.09 |
| 2026-08-17 | Juniper Investment Company, LLC | 10% owner | Open market sale | 20,000 | $10.01 |
| 2026-08-14 | Juniper Investment Company, LLC | 10% owner | Open market sale | 19,500 | $10.38 |
| 2026-06-18 | McPherron Aviva | Pres, Global Ops & Qual | Open market sale | 3,670 | $9.38 |
| 2026-06-10 | Bazaar Alan Lee | Reporting person | Grant / award | 14,965 | $0.00 |
| 2026-06-10 | Kummeth Charles R. | Reporting person | Grant / award | 14,965 | $0.00 |
| 2026-06-10 | Hannon Jason | Reporting person | Grant / award | 14,965 | $0.00 |
| 2026-06-10 | Finegan Michael | Reporting person | Grant / award | 20,721 | $0.00 |
| 2026-06-10 | CAPPS VICKIE L | Reporting person | Grant / award | 14,965 | $0.00 |
| 2026-06-10 | HENNEMAN JOHN B III | Reporting person | Grant / award | 14,965 | $0.00 |
| 2026-06-10 | BURRIS WAYNE | Reporting person | Grant / award | 14,965 | $0.00 |
| 2026-06-10 | Maniar Shweta | Reporting person | Grant / award | 14,965 | $0.00 |
| 2026-06-10 | Paolucci Michael E | Reporting person | Grant / award | 14,965 | $0.00 |
| 2026-05-22 | Juniper Investment Company, LLC | 10% owner | Open market sale | 242,000 | $10.70 |
| 2026-05-07 | HENNEMAN JOHN B III | Reporting person | Open market purchase | 5,000 | $12.26 |
| 2026-05-07 | Engine Capital Management, LP | 10% owner | Open market purchase | 18,192 | $12.20 |
| 2026-05-07 | Engine Capital Management, LP | 10% owner | Open market purchase | 9,096 | $12.15 |
| 2026-05-07 | Engine Capital Management, LP | 10% owner | Open market purchase | 1,808 | $12.20 |
| 2026-05-07 | Engine Capital Management, LP | 10% owner | Open market purchase | 904 | $12.15 |
| 2026-05-06 | Engine Capital Management, LP | 10% owner | Open market purchase | 38,154 | $12.23 |
| 2026-05-06 | Engine Capital Management, LP | 10% owner | Open market purchase | 3,792 | $12.23 |
| 2026-05-05 | Engine Capital Management, LP | 10% owner | Open market purchase | 110,039 | $11.99 |
| 2026-05-05 | Engine Capital Management, LP | 10% owner | Open market purchase | 2,911 | $11.99 |
| 2026-04-16 | Cedron Jorge Andres | CLO | Open market sale | 3,743 | $12.82 |
| 2026-03-17 | Vitale Lucas | CP&BOO | Open market sale | 4,269 | $11.92 |
| 2026-03-10 | CAPPS VICKIE L | Reporting person | Open market purchase | 100 | $12.44 |
| 2026-03-10 | CAPPS VICKIE L | Reporting person | Open market purchase | 2,400 | $12.45 |
| 2026-03-09 | CAPPS VICKIE L | Reporting person | Open market purchase | 2,500 | $12.48 |
| 2026-03-05 | Andrews Julie | CFO | Open market sale | 2,363 | $12.55 |
| 2026-03-05 | Vitale Lucas | CP&BOO | Open market sale | 1,141 | $12.55 |
| 2026-03-05 | Calafiore Massimo | President & CEO | Open market sale | 6,031 | $12.55 |
| 2026-03-05 | Fisher Patrick | President, Global Limb Recon | Open market sale | 758 | $12.55 |
| 2026-03-04 | Andrews Julie | CFO | Open market sale | 2,425 | $12.92 |
| 2026-03-04 | Vitale Lucas | CP&BOO | Open market sale | 1,171 | $12.92 |
| 2026-03-04 | Calafiore Massimo | President & CEO | Open market sale | 6,189 | $12.92 |
| 2026-03-04 | Fisher Patrick | President, Global Limb Recon | Open market sale | 778 | $12.92 |
Recent SEC filings
Official company reports and insider transaction filings. Form 4 reports a transaction; it does not by itself explain why it happened.
Source: SEC EDGAR submissions · updated 2026-10-22 00:34 UTC
| Filed | Form | Report period | Official filing |
|---|---|---|---|
| 2026-10-05 | 4 | 2026-10-01 | View on SEC.gov → |
| 2026-09-22 | 4 | 2026-09-18 | View on SEC.gov → |
| 2026-09-03 | 4 | 2026-09-01 | View on SEC.gov → |
| 2026-08-20 | 4 | 2026-08-18 | View on SEC.gov → |
| 2026-08-18 | 4 | 2026-08-14 | View on SEC.gov → |
| 2026-08-05 | 10-Q | 2026-06-30 | View on SEC.gov → |
| 2026-08-05 | 8-K | 2026-08-05 | View on SEC.gov → |
| 2026-07-02 | 8-K | 2026-07-01 | View on SEC.gov → |
| 2026-06-22 | 4 | 2026-06-18 | View on SEC.gov → |
| 2026-06-12 | 4 | 2026-06-10 | View on SEC.gov → |
| 2026-06-12 | 4 | 2026-06-10 | View on SEC.gov → |
| 2026-06-12 | 4 | 2026-06-10 | View on SEC.gov → |
Recent news
Headlines about OFIX (Orthofix Medical Inc. Common Stock (DE)). Links open the publisher — we don’t host full articles.
-
Orthofix Medical stock sits 41.79 percent below its yearly high with USD 399.8 million value - ad-hoc-news.de
ad-hoc-news.de · 2026-10-20 -
OFIX Q2 2026 Earnings: Narrower-Than-Expected Loss Delivers EPS Beat, Shares Still Slip 2.19% - Long-Term Guidance
https://www.siam.in/ · 2026-10-19 -
Orthofix Medical stock posts USD 0.39 loss per share in second quarter
AD HOC NEWS · 2026-10-17 -
Five analysts set USD 14.75 target for Orthofix Medical stock - ad-hoc-news.de
ad-hoc-news.de · 2026-10-15 -
Orthofix pays former executives $24M in damages
Yahoo · 2026-10-12 -
Orthofix Medical (OFIX) Stock Sees Fair Value Cut After Analysts Trim Q2 Outlook
Yahoo Finance · 2026-08-24 -
Orthofix Medical Sees Reimbursement Rebound, but Spine Slump Clouds Outlook
Yahoo Finance · 2026-08-16 -
Orthofix (OFIX) Q2 2026 Earnings Call Transcript
Yahoo Finance · 2026-08-12
No headlines in this category right now — try “All”.